HFA Premium Access

Prevalence and characteristics of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy: final analysis of the TTRACK study

Congress Presentation

About the speaker

Doctor Nicolas Piriou

University Hospital of Nantes, Nantes (France)
3 presentations
0 follower

4 more presentations in this session

Demographic characteristics and clinical follow-up of the 2788 transthyretin amyloid cardiomyopathy patients treated with tafamidis during the French Early Access Program (RTU)

Speaker: Professor J. Inamo (Fort de France, MQ)

Thumbnail

Age dependency of cardiovascular outcomes with the amyloidogenic p142I transthyretin variant among black individuals

Speaker: Doctor S. Selvaraj (Durham, US)

Thumbnail

Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping

Speaker: Doctor A. Ioannou (Greater London, GB)

Thumbnail

Effect of patisiran treatment in patients with hATTR amyloidosis with cardiomyopathy and polyneuropathy: post-hoc analysis of the APOLLO-B study

Speaker: Professor F. Gustafsson (Copenhagen, DK)

Thumbnail

Access the full session

Cardiac amyloidosis from epidemiology to treatment

Speakers: Doctor N. Piriou, Professor J. Inamo, Doctor S. Selvaraj, Doctor A. Ioannou, Professor F. Gustafsson
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by